Provided by Tiger Trade Technology Pte. Ltd.

Natera

366.31
+20.976.07%
Post-market: 366.950.6400+0.17%19:59 EDT
Volume:2.56M
Turnover:929.22M
Market Cap:52.46B
PE:-266.82
High:366.70
Open:350.50
Low:348.26
Close:345.34
52wk High:366.70
52wk Low:157.43
Shares:143.22M
Float Shares:139.00M
Volume Ratio:2.09
T/O Rate:1.84%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.3729
EPS(LYR):-1.5269
ROE:-12.54%
ROA:-8.08%
PB:28.80
PE(LYR):-239.91

Loading ...

U.S. RESEARCH ROUNDUP- Adobe, Caseys General Stores, Oracle

Reuters
·
Jun 12

Natera director Marcus Gail Boxer disposes of common shares worth $2.39 million

Reuters
·
Jun 10

Natera director Thomas J. Lynch Jr. files initial beneficial ownership statement

Reuters
·
Jun 10

Have Natera Insiders Been Selling Stock?

Simply Wall St.
·
Jun 09

How Investors May Respond To Natera (NTRA) Expanding Signatera MRD Reach Amid Insider Share Sale

Simply Wall St.
·
Jun 08

5 Healthcare Stocks That Are Poised To Ride AI to Gains -- Barrons.com

Dow Jones
·
Jun 07

Natera CEO Steven Chapman disposes of shares worth $7.49 million

Reuters
·
Jun 06

Natera Expands Board, Appoints Thomas Lynch as Director

TIPRANKS
·
Jun 06

Healthcare Stocks Can Benefit From AI, Too. But That Isn't the Reason to Buy Them. -- Barrons.com

Dow Jones
·
Jun 05

Natera Initiated at Neutral by Goldman Sachs

Dow Jones
·
Jun 05

Natera initiated with a Neutral at Goldman Sachs

TIPRANKS
·
Jun 05

Movement Alert|Natera Rises 5.5% in Regular Trading, Signatera Platform Secures Multiple Clinical Collaborations

Market Focus
·
Jun 04

Natera, CytoDyn collaborate to advance ctDNA-guided development

TIPRANKS
·
Jun 04

Natera partners with CytoDyn on ctDNA analysis for metastatic colorectal cancer study

Reuters
·
Jun 04

Natera President, Clinical Diagnostics Solomon Moshkevich sells USD 652,083.87 in common shares

Reuters
·
Jun 04

Natera director Roelof Botha disposes of 78,000 common shares worth $17.2 million

Reuters
·
Jun 04

Natera appoints oncologists Thomas Lynch, Eric Rubin to board

Reuters
·
Jun 03

Natera Appoints Oncology Leaders DRS. Thomas Lynch and Eric Rubin to Board of Directors

THOMSON REUTERS
·
Jun 03

Natera Coverage Assumed by Wolfe Research at Outperform

Dow Jones
·
Jun 02

Natera assumed with an Outperform at Wolfe Research

TIPRANKS
·
Jun 02